# Lexeo Therapeutics, Inc.: Form 8-K, filed Feb 5, 2026

- Company: [Lexeo Therapeutics, Inc.](/companies/lxeo.md) (CIK 1907108)
- Form: 8-K
- Filed: 2026-02-05
- Accepted by EDGAR: Feb 5, 2026, 16:17 ET
- Period: 2026-01-30
- Accession: 0001193125-26-039425
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1907108/000119312526039425/lxeo-20260130.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1907108/000119312526039425/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1907108/000119312526039425/lxeo-20260130.htm

Filed Feb 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-039425. Last ingested by Listed: Nov 14, 2026, 19:59 ET. No prices; not investment advice.
